Japan Exchange
06:03:27 30/05/2024 BST
5-day change
1st Jan Change
2,735
JPY
-1.72%
+2.17%
+45.79%
Tranche Update on Sakai Chemical Industry Co., Ltd.'s Equity Buyback Plan announced on July 23, 2018.
October 01, 2018 at 06:00 am
From July 23, 2018 to September 30, 2018, the company has repurchased 291,800 shares, representing 1.67% for ¥843.68 million. With this, the company has completed the repurchase of 291,800 shares, representing 1.67% for ¥843.68 million under the buyback announced on July 23, 2018.
Sakai Chemical Industry Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending March 31, 2024
02-13
CI
Sakai Chemical Industry Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024
02-13
CI
Sakai Chemical Industry Develops Environmental Friendly Catalyst
01-19
MT
Sakai Chemical Industry Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024
11-08
CI
Sakai Chemical Industry Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending March 31, 2024
11-08
CI
Sakai Chemical Industry Co., Ltd. Announces Dividend for the Second Quarter Ended September 30, 2023, Payable on December 01, 2023
11-08
CI
Sakai Chemical Industry Co., Ltd. Provides Consolidated Earnings Guidance for the Six Months Ending September 30, 2023 and Full Year Ending March 31, 2024
06/08/23
CI
Sakai Chemical Industry Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending March 31, 2024
06/08/23
CI
Sakai Chemical Industry Co., Ltd. Provides Dividend Guidance for the Second Quarter of Fiscal Year Ending March 31, 2024
06/08/23
CI
Sakai Chemical Industry Co., Ltd. announced that it has received ¥3.03513722 billion in funding from IA Partners Inc.
15/06/23
CI
Sakai Chemical Industry Co., Ltd. announced that it expects to receive ¥3.03513722 billion in funding from IA Partners Inc.
21/05/23
CI
Sakai Chemical Industry Co., Ltd. Reports Earnings Results for the Full Year Ended March 31, 2023
12/05/23
CI
Sakai Chemical Industry Co., Ltd. Expects to Pay Dividend for the Year Ending March 31, 2023
07/02/23
CI
Sakai Chemical Industry Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2023
07/02/23
CI
Sakai Chemical Industry Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2023
09/11/22
CI
Sakai Chemical Industry Co., Ltd. Announces Dividend for the End of Second Quarter Ended September 30, 2022, Payable on December 1, 2022; Provides Dividend Guidance for the Year Ending March 31, 2023
09/11/22
CI
Sakai Chemical Industry Installs Solar Generation System at Onahama Manufacturing Site’s Otsurugi Plant
23/09/22
MT
Sakai Chemical Industry Co., Ltd. Announces Introduction of Solar Power Generation Facilities
22/09/22
CI
Sakai Chemical's FighZinc Series Passes Safety Standards
07/09/22
MT
Sakai Chemical Industry Co., Ltd. Provides Financial Guidance for the Six Months Ending September 30, 2022 and Full Year 2023
05/08/22
CI
Sakai Chemical Recovers from Loss in FY22 over Lack of Impairment Losses
18/05/22
MT
Sakai Chemical Industry Co., Ltd. Provides Dividend Guidance for the Second Quarter 2022 and Full Year Ending March 31, 2023; Announces Dividend for the Year Ended March 31, 2022
17/05/22
CI
Sakai Chemical Industry Co., Ltd. Provides Financial Guidance for the Six Months Ending September 30, 2022 and Full Year Ending March 31, 2023
17/05/22
CI
Tranche Update on Sakai Chemical Industry Co., Ltd.'s Equity Buyback Plan announced on October 12, 2021.
23/12/21
CI
Sakai Chemical Industry Co., Ltd.'s Equity Buyback announced on October 12, 2021, has expired with 682,300 shares, representing 4.05% for ¥1,499.91 million.
21/12/21
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
SAKAI CHEMICAL INDUSTRY CO., LTD. is a Japan-based company principally manufactures and sells chemical industry products. The Company operates in two business segments. Chemical segment is involved in the manufacture and sale of chemical products. Main products include titanium products, resin additives, barium products, catalyst products, electronic materials, zinc products, functional materials, and other chemicals such as organophosphorus compounds, organic sulfur compounds, as well as water treatment agents, among others. Medical segment is involved in the manufacture and sale of pharmaceuticals and quasi drugs. Main products include barium X-ray contrast media, medical drugs for peptic ulcer & reflux esophagitis, general drugs such as cold and gastrointestinal drugs, functional foods, as well as other products such as medical devices, among others.
More about the company
Last Close Price
2,783
JPY
Average target price
2,500
JPY
Spread / Average Target
-10.17%
Consensus
1st Jan change
Capi.
+45.79% 286M +1.73% 101B -9.58% 60.39B +74.29% 48.94B +17.72% 39.17B +1.83% 31.53B +11.97% 20.15B +12.59% 16.78B +11.16% 14.22B +0.19% 13.69B
Other Commodity Chemicals
+951% of historical
More than 20 years
Our Experts
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
SAKAI CHEMICAL INDUSTRY CO., LTD. 
